{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:20:31Z","timestamp":1788790831338,"version":"build-2803163510"},"reference-count":90,"publisher":"Japan Endocrine Society","issue":"2","funder":[{"DOI":"10.13039\/501100007311","name":"German Childhood Cancer Foundation","doi-asserted-by":"crossref","award":["DKS2014.13"],"award-info":[{"award-number":["DKS2014.13"]}],"id":[{"id":"10.13039\/501100007311","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Rhythm Pharmaceuticals"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1507\/endocrj.ej25-0408","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T22:08:41Z","timestamp":1762812521000},"page":"341-353","source":"Crossref","is-referenced-by-count":12,"title":["Diagnostic criteria for acquired hypothalamic obesity \u2013 international expert guidance document"],"prefix":"10.1507","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4929-9966","authenticated-orcid":false,"given":"Hermann L.","family":"M\u00fcller","sequence":"first","affiliation":[{"name":"Department of Pediatrics and Pediatric Hematology\/Oncology, University Children\u2019s Hospital, Carl von Ossietzky Universit\u00e4t, Klinikum Oldenburg A\u00f6R, Oldenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6212-4274","authenticated-orcid":false,"given":"Tomohiro","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0143-3989","authenticated-orcid":false,"given":"Tomonobu","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0011-0325","authenticated-orcid":false,"given":"Tsuyoshi","family":"Isojima","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Toranomon Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1271-1577","authenticated-orcid":false,"given":"Jun","family":"Mori","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology, Metabolism and Nephrology, Children\u2019s Medical Center, Osaka City General Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3695-0479","authenticated-orcid":false,"given":"Masamichi","family":"Kurosaki","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Department of Brain and Neurosciences, Faculty of Medicine Tottori University, Tottori, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nishioka","sequence":"additional","affiliation":[{"name":"Department of Hypothalamic and Pituitary Surgery, Toranomon Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Jin","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Brain and Cognitive Sciences, Department of Anatomy and Cell Biology, Seoul National University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2494-9902","authenticated-orcid":false,"given":"A Ram","family":"Hong","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2477-5199","authenticated-orcid":false,"given":"Ja Hye","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3746-1997","authenticated-orcid":false,"given":"Hiroshi","family":"Arima","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Tokai National Higher Education and Research System, Nagoya University, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 M\u00fcller HL, Tauber M, Lawson EA, \u00d6zyurt J, Bison B, et al. (2022) Hypothalamic syndrome. Nat Rev Dis Primers 8: 24.","DOI":"10.1038\/s41572-022-00351-z"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Gan HW, Cerbone M, Dattani MT (2024) Appetite- and weight-regulating neuroendocrine circuitry in hypothalamic obesity. Endocr Rev 45: 309\u2013342.","DOI":"10.1210\/endrev\/bnad033"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Holmer H, Pozarek G, Wirf\u00e4lt E, Popovic V, Ekman B, et al. (2010) Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma. J Clin Endocrinol Metab 95: 5395\u20135402.","DOI":"10.1210\/jc.2010-0993"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Tran LT, Park S, Kim SK, Lee JS, Kim KW, et al. (2022) Hypothalamic control of energy expenditure and thermogenesis. Exp Mol Med 54: 358\u2013369.","DOI":"10.1038\/s12276-022-00741-z"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Fountas A, Coulden A, Fern\u00e1ndez-Garc\u00eda S, Tsermoulas G, Allotey J, et al. (2024) Central diabetes insipidus (vasopressin deficiency) after surgery for pituitary tumours: a systematic review and meta-analysis. Eur J Endocrinol 191: S1\u2013S13.","DOI":"10.1093\/ejendo\/lvae084"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 M\u00fcller HL (2010) Increased daytime sleepiness in patients with childhood craniopharyngioma and hypothalamic tumor involvement: review of the literature and perspectives. Int J Endocrinol 2010: 519607.","DOI":"10.1155\/2010\/519607"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 \u00d6zyurt J, Thiel CM, Lorenzen A, Gebhardt U, Calaminus G, et al. (2014) Neuropsychological outcome in patients with childhood craniopharyngioma and hypothalamic involvement. J Pediatr 164: 876\u2013881.e874.","DOI":"10.1016\/j.jpeds.2013.12.010"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Roth CL, McCormack SE (2024) Acquired hypothalamic obesity: a clinical overview and update. Diabetes Obes Metab 26 Suppl 2: 34\u201345.","DOI":"10.1111\/dom.15530"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Argente J, Farooqi IS, Chowen JA, K\u00fchnen P, L\u00f3pez M, et al. (2025) Hypothalamic obesity: from basic mechanisms to clinical perspectives. Lancet Diabetes Endocrinol 13: 57\u201368.","DOI":"10.1016\/S2213-8587(24)00283-3"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 M\u00fcller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera JP, Puget S (2019) Craniopharyngioma. Nat Rev Dis Primers 5: 75.","DOI":"10.1038\/s41572-019-0125-9"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Picariello S, Cerbone M, D\u2019Arco F, Gan HW, O\u2019Hare P, et al. (2022) A 40-year cohort study of evolving hypothalamic dysfunction in infants and young children (&lt;3 years) with optic pathway gliomas. Cancers (Basel) 14: 747.","DOI":"10.3390\/cancers14030747"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 van Schaik J, Hoving EW, M\u00fcller HL, van Santen HM (2021) Hypothalamic-pituitary outcome after treatment for childhood craniopharyngioma. Front Horm Res 54: 47\u201357.","DOI":"10.1159\/000515318"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 T\u00fcre U, De Bellis A, Harput MV, Bellastella G, Topcuoglu M, et al. (2021) Hypothalamitis: a novel autoimmune endocrine disease. a literature review and case report. J Clin Endocrinol Metab 106: e415\u2013e429.","DOI":"10.1210\/clinem\/dgaa771"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Harvengt J, Gernay C, Mastouri M, Farhat N, Lebrethon MC, et al. (2020) ROHHAD(NET) syndrome: systematic review of the clinical timeline and recommendations for diagnosis and prognosis. J Clin Endocrinol Metab 105: dgaa247.","DOI":"10.1210\/clinem\/dgaa247"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Salman MS, Ruth CA, Yogendran MS, Lix LM (2025) Morbidities and comorbidities associated with optic nerve hypoplasia and septo-optic-pituitary dysplasia. Dev Med Child Neurol 67: 941\u2013952.","DOI":"10.1111\/dmcn.16235"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Witte J, Surmann B, Batram M, Weinert M, Flume M, et al. (2024) Hypothalamic obesity: Epidemiology in rare sellar\/suprasellar tumors-A German claims database analysis. J Neuroendocrinol 36: e13439.","DOI":"10.1111\/jne.13439"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 van Iersel L, van Santen HM, Potter B, Li Z, Conklin HM, et al. (2020) Clinical impact of hypothalamic-pituitary disorders after conformal radiation therapy for pediatric low-grade glioma or ependymoma. Pediatr Blood Cancer 67: e28723.","DOI":"10.1002\/pbc.28723"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Einaudi S, Bondone C (2007) The effects of head trauma on hypothalamic-pituitary function in children and adolescents. Curr Opin Pediatr 19: 465\u2013470.","DOI":"10.1097\/MOP.0b013e3281ab6eeb"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Hoffmann A, Boekhoff S, Gebhardt U, Sterkenburg AS, Daubenb\u00fcchel AM, et al. (2015) History before diagnosis in childhood craniopharyngioma: associations with initial presentation and long-term prognosis. Eur J Endocrinol 173: 853\u2013862.","DOI":"10.1530\/EJE-15-0709"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Haliloglu B, Atay Z, Guran T, Abal\u0131 S, Bas S, et al. (2016) Risk factors for mortality caused by hypothalamic obesity in children with hypothalamic tumours. Pediatr Obes 11: 383\u2013388.","DOI":"10.1111\/ijpo.12076"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 van Iersel L, Brokke KE, Adan RAH, Bulthuis LCM, van den Akker ELT, et al. (2019) Pathophysiology and individualized treatment of hypothalamic obesity following craniopharyngioma and other suprasellar tumors: a systematic review. Endocr Rev 40: 193\u2013235.","DOI":"10.1210\/er.2018-00017"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Kayadjanian N, Hsu EA, Wood AM, Carson DS (2023) Caregiver burden and its relationship to health-related quality of life in craniopharyngioma survivors. J Clin Endocrinol Metab 109: e76\u2013e87.","DOI":"10.1210\/clinem\/dgad488"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 van Roessel I, de Graaf JP, Biermasz NR, Charmandari E, van Santen HM (2023) Acquired hypothalamic dysfunction in childhood: \u2018what do patients need?\u2019\u2014an Endo-ERN survey. Endocr Connect 12: e230147.","DOI":"10.1530\/EC-23-0147"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 M\u00fcller HL, Faldum A, Etavard-Gorris N, Gebhardt U, Oeverink R, et al. (2003) Functional capacity, obesity and hypothalamic involvement: cross-sectional study on 212 patients with childhood craniopharyngioma. Klin Padiatr 215: 310\u2013314.","DOI":"10.1055\/s-2003-45499"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 van Santen HM, van Schaik J, van Roessel I, Beckhaus J, Boekhoff S, et al. (2023) Diagnostic criteria for the hypothalamic syndrome in childhood. Eur J Endocrinol 188: lvad009.","DOI":"10.1530\/endoabs.90.P686"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Hoffmann A, Gebhardt U, Sterkenburg AS, Warmuth-Metz M, M\u00fcller HL (2014) Diencephalic syndrome in childhood craniopharyngioma\u2014results of German multicenter studies on 485 long-term survivors of childhood craniopharyngioma. J Clin Endocrinol Metab 99: 3972\u20133977.","DOI":"10.1210\/jc.2014-1680"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 M\u00fcller HL, Emser A, Faldum A, Bruhnken G, Etavard-Gorris N, et al. (2004) Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab 89: 3298\u20133305.","DOI":"10.1210\/jc.2003-031751"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Daubenb\u00fcchel AM, M\u00fcller HL (2015) Neuroendocrine disorders in pediatric craniopharyngioma patients. J Clin Med 4: 389\u2013413.","DOI":"10.3390\/jcm4030389"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 M\u00fcller HL (2013) Paediatrics: surgical strategy and quality of life in craniopharyngioma. Nat Rev Endocrinol 9: 447\u2013449.","DOI":"10.1038\/nrendo.2013.125"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Dykens EM, Maxwell MA, Pantino E, Kossler R, Roof E (2007) Assessment of hyperphagia in Prader-Willi syndrome. Obesity (Silver Spring) 15: 1816\u20131826.","DOI":"10.1038\/oby.2007.216"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Lee M, Park MJ, Lee KH, Kim JH, Choi HJ, et al. (2023) Obesity mechanism after hypothalamic damage: cohort analysis of neuroimaging, psychological, cognitive, and clinical phenotyping data. Front Endocrinol (Lausanne) 14: 1114409.","DOI":"10.3389\/fendo.2023.1114409"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Hoffmann A, Postma FP, Sterkenburg AS, Gebhardt U, M\u00fcller HL (2015) Eating behavior, weight problems and eating disorders in 101 long-term survivors of childhood-onset craniopharyngioma. J Pediatr Endocrinol Metab 28: 35\u201343.","DOI":"10.1515\/jpem-2014-0415"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 M\u00fcller HL, Bueb K, Bartels U, Roth C, Harz K, et al. (2001) Obesity after childhood craniopharyngioma\u2014German multicenter study on pre-operative risk factors and quality of life. Klin Padiatr 213: 244\u2013249.","DOI":"10.1055\/s-2001-16855"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Beckhaus J, Friedrich C, Boekhoff S, Calaminus G, Bison B, et al. (2023) Outcome after pediatric craniopharyngioma: the role of age at diagnosis and hypothalamic damage. Eur J Endocrinol 188: lvad027.","DOI":"10.1530\/endoabs.90.P118"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Eveslage M, Calaminus G, Warmuth-Metz M, Kortmann RD, Pohl F, et al. (2019) The postopera tive quality of life in children and adolescents with craniopharyngioma. Dtsch Arztebl Int 116: 321\u2013328.","DOI":"10.3238\/arztebl.2019.0321"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Rovani S, Butler V, Samara-Boustani D, Pinto G, Gonzalez-Briceno L, et al. (2024) Long-term weight gain in children with craniopharyngioma. Eur J Endocrinol 190: 363\u2013373.","DOI":"10.1093\/ejendo\/lvae044"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Bogusz A, Boekhoff S, Warmuth-Metz M, Calaminus G, Eveslage M, et al. (2019) Posterior hypothalamus-sparing surgery improves outcome after childhood craniopharyngioma. Endocr Connect 8: 481\u2013492.","DOI":"10.1530\/EC-19-0074"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 M\u00fcller HL (2025) Management of acquired hypothalamic obesity after childhood-onset craniopharyngioma-a narrative review. Biomedicines 13: 1016.","DOI":"10.3390\/biomedicines13051016"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 M\u00fcller HL, Gebhardt U, Teske C, Faldum A, Zwiener I, et al. (2011) Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up. Eur J Endocrinol 165: 17\u201324.","DOI":"10.1530\/EJE-11-0158"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Sterkenburg AS, Hoffmann A, Gebhardt U, Warmuth-Metz M, Daubenb\u00fcchel AM, et al. (2015) Survival, hypothalamic obesity, and neuropsychological\/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. Neuro Oncol 17: 1029\u20131038.","DOI":"10.1093\/neuonc\/nov044"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 M\u00fcller HL, Gebhardt U, Faldum A, Warmuth-Metz M, Pietsch T, et al. (2012) Xanthogranuloma, Rathke\u2019s cyst, and childhood craniopharyngioma: results of prospective multinational studies of children and adolescents with rare sellar malformations. J Clin Endocrinol Metab 97: 3935\u20133943.","DOI":"10.1210\/jc.2012-2069"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Beckhaus J, Eveslage M, Bison B, Friedrich C, M\u00fcller HL (2024) Impact of parental body mass index at diagnosis on obesity in survivors of pediatric craniopharyngioma. Endocr Connect 13: e240126.","DOI":"10.1530\/EC-24-0126"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Eagle SR, Puccio AM, Nelson LD, McCrea M, Giacino J, et al. (2023) Association of obesity with mild traumatic brain injury symptoms, inflammatory profile, quality of life and functional outcomes: a TRACK-TBI Study. J Neurol Neurosurg Psychiatry 94: 1012\u20131017.","DOI":"10.1136\/jnnp-2023-331562"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Bavisetty S, Bavisetty S, McArthur DL, Dusick JR, Wang C, et al. (2008) Chronic hypopituitarism after traumatic brain injury: risk assessment and relationship to outcome. Neurosurgery 62: 1080\u20131093; discussion 1093\u20131084.","DOI":"10.1227\/01.NEU.0000313577.16309.CD"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Zainudin MF, Yee CM, Nyein Yin K (2024) Morbid hunger and hyperphagia post-traumatic brain injury in a young male: good prognosis with escitalopram and multidisciplinary rehabilitation. Brain Inj 38: 1147\u20131151.","DOI":"10.1080\/02699052.2024.2378838"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Zacharia SS, Thomas R, Johnson JT, Kapoor N, Ramanathan S, et al. (2024) Neuroendocrine challenges and clinical outcomes in men with chronic traumatic brain injury: a cross-sectional study. Pituitary 27: 693\u2013704.","DOI":"10.1007\/s11102-024-01433-9"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Apps JR, Muller HL, Hankinson TC, Yock TI, Martinez-Barbera JP (2023) Contemporary Biological Insights and Clinical Management of Craniopharyngioma. Endocr Rev 44: 518\u2013538.","DOI":"10.1210\/endrev\/bnac035"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Roth CL, Scimia C, Shoemaker AH, Gottschalk M, Miller J, et al. (2024) Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial. Lancet Diabetes Endocrinol 12: 380\u2013389.","DOI":"10.1016\/S2213-8587(24)00087-1"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49 Mason PW, Krawiecki N, Meacham LR (2002) The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Arch Pediatr Adolesc Med 156: 887\u2013892.","DOI":"10.1001\/archpedi.156.9.887"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50 van Santen SS, Wolf P, Kremenevski N, Boguszewski CL, Beiglb\u00f6ck H, et al. (2021) Bariatric surgery for hypothalamic obesity in craniopharyngioma patients: a retrospective, matched case-control study. J Clin Endocrinol Metab 106: e4734\u2013e4745.","DOI":"10.1210\/clinem\/dgab518"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51 Faucher P, Carette C, Jannot AS, Gatta-Cherifi B, Van Straaten A, et al. (2022) Five-year changes in weight and diabetes status after bariatric surgery for craniopharyngioma-related hypothalamic obesity: a case-control study. Obes Surg 32: 2321\u20132331.","DOI":"10.1007\/s11695-022-06079-9"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52 Garrez I, Lapauw B, Van Nieuwenhove Y (2020) Bariatric surgery for treatment of hypothalamic obesity after craniopharyngioma therapy: a matched case-control study. Obes Surg 30: 2439\u20132444.","DOI":"10.1007\/s11695-020-04391-w"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53 Bretault M, Boillot A, Muzard L, Poitou C, Oppert JM, et al. (2013) Clinical review: bariatric surgery following treatment for craniopharyngioma: a systematic review and individual-level data meta-analysis. J Clin Endocrinol Metab 98: 2239\u20132246.","DOI":"10.1210\/jc.2012-4184"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54 M\u00fcller HL, Gebhardt U, Maroske J, Hanisch E (2011) Long-term follow-up of morbidly obese patients with childhood craniopharyngioma after laparoscopic adjustable gastric banding (LAGB). Klin Padiatr 223: 372\u2013373.","DOI":"10.1055\/s-0031-1284420"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55 M\u00fcller HL, Gebhardt U, Wessel V, Schr\u00f6der S, Kolb R, et al. (2007) First experiences with laparoscopic adjustable gastric banding (LAGB) in the treatment of patients with childhood craniopharyngioma and morbid obesity. Klin Padiatr 219: 323\u2013325.","DOI":"10.1055\/s-2007-985848"},{"key":"56","doi-asserted-by":"publisher","unstructured":"56 Gjersdal E, Larsen LB, Ettrup KS, Vestergaard P, Nielsen EH, et al. (2024) Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma. Pituitary 27: 723\u2013730.","DOI":"10.1007\/s11102-024-01426-8"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57 Hamilton JK, Conwell LS, Syme C, Ahmet A, Jeffery A, et al. (2011) Hypothalamic obesity following craniopharyngioma surgery: results of a pilot trial of combined diazoxide and metformin therapy. Int J Pediatr Endocrinol 2011: 417949.","DOI":"10.1155\/2011\/417949"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58 Weismann D, Pelka T, Bender G, Jurowich C, Fassnacht M, et al. (2013) Bariatric surgery for morbid obesity in craniopharyngioma. Clin Endocrinol (Oxf) 78: 385\u2013390.","DOI":"10.1111\/j.1365-2265.2012.04409.x"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59 Wijnen M, Olsson DS, van den Heuvel-Eibrink MM, Wallenius V, Janssen JA, et al. (2017) Efficacy and safety of bariatric surgery for craniopharyngioma-related hypothalamic obesity: a matched case-control study with 2 years of follow-up. Int J Obes (Lond) 41: 210\u2013216.","DOI":"10.1038\/ijo.2016.195"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60 Trotta M, Da Broi J, Salerno A, Testa RM, Marinari GM (2017) Sleeve gastrectomy leads to easy management of hormone replacement therapy and good weight loss in patients treated for craniopharyngioma. Updates Surg 69: 95\u201399.","DOI":"10.1007\/s13304-017-0425-0"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61 Denzer C, Denzer F, Lennerz BS, Vollbach H, Lustig RH, et al. (2019) Treatment of hypothalamic obesity with dextroamphetamine: a case series. Obes Facts 12: 91\u2013102.","DOI":"10.1159\/000495851"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62 van Schaik J, Welling MS, de Groot CJ, van Eck JP, Juriaans A, et al. (2022) Dextroamphetamine treatment in children with hypothalamic obesity. Front Endocrinol (Lausanne) 13: 845937.","DOI":"10.3389\/fendo.2022.845937"},{"key":"63","doi-asserted-by":"publisher","unstructured":"63 Svendstrup M, Rasmussen AK, Kistorp C, Klose M, Andreassen M (2024) Semaglutide treatment of hypothalamic obesity\u2014a real-life data study. Pituitary 27: 685\u2013692.","DOI":"10.1007\/s11102-024-01429-5"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64 Zoicas F, Droste M, Mayr B, Buchfelder M, Sch\u00f6fl C (2013) GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases. Eur J Endocrinol 168: 699\u2013706.","DOI":"10.1530\/EJE-12-0997"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65 Lomenick JP, Buchowski MS, Shoemaker AH (2016) A 52-week pilot study of the effects of exenatide on body weight in patients with hypothalamic obesity. Obesity (Silver Spring) 24: 1222\u20131225.","DOI":"10.1002\/oby.21493"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66 Huynh K, Klose M, Krogsgaard K, Drejer J, Byberg S, et al. (2022) Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity. Eur J Endocrinol 186: 687\u2013700.","DOI":"10.1530\/EJE-21-0972"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67 Lustig RH, Rose SR, Burghen GA, Velasquez-Mieyer P, Broome DC, et al. (1999) Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist. J Pediatr 135: 162\u2013168.","DOI":"10.1016\/S0022-3476(99)70017-X"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68 Lustig RH, Hinds PS, Ringwald-Smith K, Christensen RK, Kaste SC, et al. (2003) Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab 88: 2586\u20132592.","DOI":"10.1210\/jc.2002-030003"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69 Fernandes JK, Klein MJ, Ater JL, Kuttesch JF, Vassilopoulou-Sellin R (2002) Triiodothyronine supplementation for hypothalamic obesity. Metabolism 51: 1381\u20131383.","DOI":"10.1053\/meta.2002.35591"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70 Greenway FL, Bray GA (2008) Treatment of hypothalamic obesity with caffeine and ephedrine. Endocr Pract 14: 697\u2013703.","DOI":"10.4158\/EP.14.6.697"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71 Rakhshani N, Jeffery AS, Schulte F, Barrera M, Atenafu EG, et al. (2010) Evaluation of a comprehensive care clinic model for children with brain tumor and risk for hypothalamic obesity. Obesity (Silver Spring) 18: 1768\u20131774.","DOI":"10.1038\/oby.2009.491"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72 Gatta B, Nunes ML, Bailacq-Auder C, Etchechoury L, Collet D, et al. (2013) Is bariatric surgery really inefficient in hypothalamic obesity? Clin Endocrinol (Oxf) 78: 636\u2013638.","DOI":"10.1111\/cen.12031"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73 van Santen HM, Schouten-Meeteren AY, Serlie M, Meijneke RW, van Trotsenburg AS, et al. (2015) Effects of T3 treatment on brown adipose tissue and energy expenditure in a patient with craniopharyngioma and hypothalamic obesity. J Pediatr Endocrinol Metab 28: 53\u201357.","DOI":"10.1515\/jpem-2014-0337"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74 Harat M, Ruda\u015b M, Zieli\u0144ski P, Birska J, Sokal P (2016) Nucleus accumbens stimulation in pathological obesity. Neurol Neurochir Pol 50: 207\u2013210.","DOI":"10.1016\/j.pjnns.2016.01.014"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75 Hsu EA, Miller JL, Perez FA, Roth CL (2018) Oxytocin and naltrexone successfully treat hypothalamic obesity in a boy post-craniopharyngioma resection. J Clin Endocrinol Metab 103: 370\u2013375.","DOI":"10.1210\/jc.2017-02080"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76 Smith DK, Sarfeh J, Howard L (1983) Truncal vagotomy in hypothalamic obesity. Lancet 1: 1330\u20131331.","DOI":"10.1016\/S0140-6736(83)92437-6"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77 Inge TH, Pfluger P, Zeller M, Rose SR, Burget L, et al. (2007) Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapy. Nat Clin Pract Endocrinol Metab 3: 606\u2013609.","DOI":"10.1038\/ncpendmet0579"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78 Schultes B, Ernst B, Schmid F, Thurnheer M (2009) Distal gastric bypass surgery for the treatment of hypothalamic obesity after childhood craniopharyngioma. Eur J Endocrinol 161: 201\u2013206.","DOI":"10.1530\/EJE-09-0079"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79 Page-Wilson G, Wardlaw SL, Khandji AG, Korner J (2012) Hypothalamic obesity in patients with craniopharyngioma: treatment approaches and the emerging role of gastric bypass surgery. Pituitary 15: 84\u201392.","DOI":"10.1007\/s11102-011-0349-5"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80 Rottembourg D, O\u2019Gorman CS, Urbach S, Garneau PY, Langer JC, et al. (2009) Outcome after bariatric surgery in two adolescents with hypothalamic obesity following treatment of craniopharyngioma. J Pediatr Endocrinol Metab 22: 867\u2013872.","DOI":"10.1515\/JPEM.2009.22.9.867"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81 Lee YJ, Backeljauw PF, Kelly PD, Verdi PD, Redmond GP (1992) Successful weight loss with protein-sparing modified fast in a morbidly obese boy with panhypopituitarism, diabetes insipidus, and defective thirst regulation. Clin Pediatr (Phila) 31: 234\u2013236.","DOI":"10.1177\/000992289203100409"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82 Jordaan GP, Roberts MC, Emsley RA (1996) Serotonergic agents in the treatment of hypothalamic obesity syndrome: a case report. Int J Eat Disord 20: 111\u2013113.","DOI":"10.1002\/(SICI)1098-108X(199607)20:1<111::AID-EAT13>3.0.CO;2-7"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83 Thondam SK, Cuthbertson DJ, Aditya BS, Macfarlane IA, Wilding JP, et al. (2012) A glucagon-like peptide-1 (GLP-1) receptor agonist in the treatment for hypothalamic obesity complicated by type 2 diabetes mellitus. Clin Endocrinol (Oxf) 77: 635\u2013637.","DOI":"10.1111\/j.1365-2265.2012.04368.x"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84 Simmons JH, Shoemaker AH, Roth CL (2012) Treatment with glucagon-like Peptide-1 agonist exendin-4 in a patient with hypothalamic obesity secondary to intracranial tumor. Horm Res Paediatr 78: 54\u201358.","DOI":"10.1159\/000339469"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85 Heymsfield SB, Cl\u00e9ment K, Dubern B, Goldstone AP, Haqq AM, et al. (2025) Defining hyperphagia for improved diagnosis and management of MC4R pathway-associated disease: a roundtable summary. Curr Obes Rep 14: 13.","DOI":"10.1007\/s13679-025-00616-0"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86 Dimitri P, Roth CL (2024) Treatment of hypothalamic obesity with GLP-1 analogs. J Endocr Soc 9: bvae200.","DOI":"10.1210\/jendso\/bvae200"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87 Roth CL (2025) Setmelanotide for the treatment of severe early-childhood genetic obesity. Lancet Diabetes Endocrinol 13: 3\u20134.","DOI":"10.1016\/S2213-8587(24)00312-7"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88 Van Roessel I, Van Den Brink M, Dekker J, Ruitenburg-van Essen BG, Tissing WJE, et al. (2024) Feasibility, safety, and efficacy of dietary or lifestyle interventions for hypothalamic obesity: a systematic review. Clin Nutr 43: 1798\u20131811.","DOI":"10.1016\/j.clnu.2024.05.028"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89 Puget S, Garnett M, Wray A, Grill J, Habrand JL, et al. (2007) Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurg 106: 3\u201312.","DOI":"10.3171\/ped.2007.106.1.3"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90 de Vile CJ, Grant DB, Hayward RD, Kendall BE, Neville BG, et al. (1996) Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging. J Clin Endocrinol Metab 81: 2734\u20132737.","DOI":"10.1210\/jcem.81.7.8675604"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/2\/73_EJ25-0408\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:25:13Z","timestamp":1770434713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/2\/73_EJ25-0408\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej25-0408","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"EJ25-0408"}}